健友股份(603707.SH)：获得美国FDA盐酸尼卡地平注射液药品注册批件

Core Viewpoint - The company, Jianyou Co., Ltd. (603707.SH), has received approval from the U.S. Food and Drug Administration (FDA) for its Nicardipine Hydrochloride Injection, which is indicated for short-term treatment of hypertension when oral therapy is not feasible [1] Group 1 - The approved product is Nicardipine Hydrochloride Injection, with a dosage of 25mg/10mL (2.5mg/mL) [1] - The ANDA number for the approved product is 216819 [1] - The indication for this medication is specifically for the short-term treatment of hypertension [1]